Table of Content

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15

2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 26
2.4 Emerging Opportunities and Market Trends 29
2.5 Porter’s Fiver Forces Analysis 33

3 Segmentation of Europe Market by Treatment Type 37
3.1 Market Overview by Treatment Type 37
3.2 Medication 39
3.3 Stem Cell Therapy 41
3.4 Other Treatments 42

4 Segmentation of Europe Market by ALS Type 43
4.1 Market Overview by ALS Type 43
4.2 Sporadic ALS 45
4.3 Familial ALS 46

5 Segmentation of Europe Market by Distribution Channel 47
5.1 Market Overview by Distribution Channel 47
5.2 Hospital Pharmacies 49
5.3 Retail Pharmacies 50
5.4 Online Pharmacies 51
5.5 Other Distribution Channels 52

6 European Market 2020-2027 by Country 53
6.1 Overview of European Market 53
6.2 UK 56
6.3 France 58
6.4 Germany 60
6.5 Spain 62
6.6 Italy 64
6.7 Russia 66
6.8 Rest of European Market 68

7 Competitive Landscape 70
7.1 Overview of Key Vendors 70
7.2 New Product Launch, Partnership, Investment, and M&A 73
7.3 Company Profiles 74
AB Science SA 74
Amylyx Pharmaceuticals Inc. 76
Biogen Inc. 77
Biohaven Pharmaceutical Holding Co., Ltd. 78
BrainStorm Cell Limited 79
Corestem, Inc. 80
F.Hoffmann-La Roche AG 81
Ionis Pharmaceuticals, Inc. 82
Mitsubishi Tanabe Pharma Corporation 83
Otsuka Pharmaceutical Co., Ltd. 84
Sun Pharmaceutical Industries Ltd. 85
RELATED REPORTS 86
?



List of Figures

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 15
Figure 4. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 25
Figure 8. Primary Restraints and Impact Factors of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market 26
Figure 9. Investment Opportunity Analysis 30
Figure 10. Porter’s Fiver Forces Analysis of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market 33
Figure 11. Breakdown of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2020-2027, % of Revenue 37
Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Treatment Type, Value ($ mn) and Share (%) 38
Figure 13. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication, 2017-2027, $ mn 39
Figure 14. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Stem Cell Therapy, 2017-2027, $ mn 41
Figure 15. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Treatments, 2017-2027, $ mn 42
Figure 16. Breakdown of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2020-2027, % of Revenue 43
Figure 17. Contribution to Europe 2021-2027 Cumulative Revenue by ALS Type, Value ($ mn) and Share (%) 44
Figure 18. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Sporadic ALS, 2017-2027, $ mn 45
Figure 19. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Familial ALS, 2017-2027, $ mn 46
Figure 20. Breakdown of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2020-2027, % of Revenue 48
Figure 21. Contribution to Europe 2021-2027 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 48
Figure 22. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital Pharmacies, 2017-2027, $ mn 49
Figure 23. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Retail Pharmacies, 2017-2027, $ mn 50
Figure 24. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Online Pharmacies, 2017-2027, $ mn 51
Figure 25. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Distribution Channels, 2017-2027, $ mn 52
Figure 26. Breakdown of European Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 54
Figure 27. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 55
Figure 28. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in UK, 2017-2027, $ mn 56
Figure 29. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in France, 2017-2027, $ mn 58
Figure 30. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Germany, 2017-2027, $ mn 60
Figure 31. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Spain, 2017-2027, $ mn 62
Figure 32. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Italy, 2017-2027, $ mn 64
Figure 33. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Russia, 2017-2027, $ mn 66
Figure 34. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of Europe, 2017-2027, $ mn 68
Figure 35. Growth Stage of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Industry over the Forecast Period 70

List of Tables

Table 1. Snapshot of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Balanced Perspective, 2020-2027 16
Table 2. Growth Rate of World GDP, 2020-2022 19
Table 3. Main Product Trends and Market Opportunities in Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market 29
Table 4. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 37
Table 5. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication by Type, 2017-2027, $ mn 40
Table 6. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 43
Table 7. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 47
Table 8. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 55
Table 9. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 57
Table 10. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 57
Table 11. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 57
Table 12. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 59
Table 13. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 59
Table 14. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 59
Table 15. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 61
Table 16. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 61
Table 17. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 61
Table 18. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 63
Table 19. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 63
Table 20. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 63
Table 21. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 65
Table 22. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 65
Table 23. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 65
Table 24. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 67
Table 25. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 67
Table 26. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 67
Table 27. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of Europe by Country, 2017-2027, $ mn 69
Table 28. AB Science SA: Company Snapshot 74
Table 29. AB Science SA: Business Segmentation 74
Table 30. AB Science SA: Product Portfolio 75
Table 31. AB Science SA: Revenue, 2017-2019, $ mn 75